Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468

Divya B Kenchappa1,2, Olga Korolkova1, Nobelle Sakwe3

  • 1Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Blvd., Nashville, TN 37208.

Journal of Pharmacy and Pharmacology Research
|March 24, 2025
PubMed
Summary

Fetuin-A promotes triple-negative breast cancer (TNBC) growth and invasion by activating Toll-like receptor 4 (TLR4) signaling. Inhibiting TLR4 blocks these fetuin-A-mediated effects, suggesting a therapeutic target for TNBC.